Prescription Drug Affordability Board

The Washington State Health Care Authority is awarding a three‑year, sole‑source contract to IPD Analytics, LLC for an upgrade of its proprietary data platform to the Premier SaaS tier. The upgraded platform will deliver comprehensive pharmaceutical pipeline insights, rebate and discount data, and legal‑policy analysis needed by the Prescription Drug Affordability Board (PDAB) to conduct drug‑affordability reviews and set Upper Payment Limits. The contract value is $484,330.10, representing an 18 % cost saving over base‑level pricing, and includes optional three‑year extensions. • Scope: SaaS subscription (Premier tier) providing pipeline, pricing, rebate, discount, and qualitative policy data. • Term: 3 years (July 1 2026 – Dec 31 2029) with optional extensions. • Funding: State budget, split between PDAB and CQCT, with a total estimated value of ≈ $484 K.